Literature DB >> 33333791

One Multilocus Genomic Variation Is Responsible for a Severe Charcot-Marie-Tooth Axonal Form.

Federica Miressi1, Corinne Magdelaine1,2, Pascal Cintas3, Sylvie Bourthoumieux1,4, Angélique Nizou1, Paco Derouault5, Frédéric Favreau1,2, Franck Sturtz1,2, Pierre-Antoine Faye1,2, Anne-Sophie Lia1,2,5.   

Abstract

Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited disorders affecting the peripheral nervous system, with a prevalence of 1/2500. So far, mutations in more than 80 genes have been identified causing either demyelinating forms (CMT1) or axonal forms (CMT2). Consequentially, the genotype-phenotype correlation is not always easy to assess. Diagnosis could require multiple analysis before the correct causative mutation is detected. Moreover, it seems that approximately 5% of overall diagnoses for genetic diseases involves multiple genomic loci, although they are often underestimated or underreported. In particular, the combination of multiple variants is rarely described in CMT pathology and often neglected during the diagnostic process. Here, we present the complex genetic analysis of a family including two CMT cases with various severities. Interestingly, next generation sequencing (NGS) associated with Cov'Cop analysis, allowing structural variants (SV) detection, highlighted variations in MORC2 (microrchidia family CW-type zinc-finger 2) and AARS1 (alanyl-tRNA-synthetase) genes for one patient and an additional mutation in MFN2 (Mitofusin 2) in the more affected patient.

Entities:  

Keywords:  CNV; Charcot–Marie–Tooth; NGS; diagnosis; multilocus disease

Year:  2020        PMID: 33333791     DOI: 10.3390/brainsci10120986

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  3 in total

Review 1.  Microrchidia CW-Type Zinc Finger 2, a Chromatin Modifier in a Spectrum of Peripheral Neuropathies.

Authors:  Arnaud Jacquier; Simon Roubille; Patrick Lomonte; Laurent Schaeffer
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

Review 2.  Next-Generation Sequencing Technologies and Neurogenetic Diseases.

Authors:  Hui Sun; Xiao-Rong Shen; Zi-Bing Fang; Zong-Zhi Jiang; Xiao-Jing Wei; Zi-Yi Wang; Xue-Fan Yu
Journal:  Life (Basel)       Date:  2021-04-19

3.  Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis.

Authors:  Fabiana Longo; Daniele De Ritis; Annarita Miluzio; Davide Fraticelli; Jonathan Baets; Marina Scarlato; Filippo M Santorelli; Stefano Biffo; Francesca Maltecca
Journal:  Neurology       Date:  2021-10-14       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.